RBC Capital Maintains Outperform on Hinge Health, Raises Price Target to $135
Benzinga Newsdesk 3 days ago
Analyst RatingsNewsPrice Target
RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $110 to $135.
RBC Capital analyst Rishi Jaluria maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price target from $110 to $135.